Jason Bock PhD - Founder and CEO, CTMC

Send us Fan MailIn this episode my guest is Jason Bock PhD.  Jason is the CEO of CTMC / A joint venture between Resilience and MD Anderson Cancer Center. Jason Bock has been in biotech and biopharma for over 20 years, mostly in Biologics development. He founded Ctmc, a technology platform to industrialize cell therapies and bring them into the MD Anderson Clinic. Ctmc is a joint venture between MD Anderson and National Resilience. Ctmc partners with preclinical biotech, MD Anderson faculty, and Factus to provide a capital-efficient model to bring impactful single dose curative treatments to patients. Ctmc has filed three INDs in the first six months since it spun off on novel cell therapies brought into the clinic. Ctmc has progressed on the seven clinical studies that it supports. Ctmc recently announced that it was the recipient of a $9.1 million grant to help develop cell therapy platforms and improved ways of making these cell therapies. Jason is inspired by the patients and patient-centricity. He is concerned about the challenges, logistical and manufacturing challenges with autologous cell therapy. What excites him is the potential to transform healthcare and be single-dose curative treatments.